Published in Genome Biol on June 18, 2010
DNA methylation: roles in mammalian development. Nat Rev Genet (2013) 6.65
Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci (2011) 3.27
Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes. Nucleic Acids Res (2012) 1.60
A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res (2011) 1.49
Global methylation patterns in idiopathic pulmonary fibrosis. PLoS One (2012) 1.44
Distinct epigenomic features in end-stage failing human hearts. Circulation (2011) 1.39
Cytidine deaminases: AIDing DNA demethylation? Genes Dev (2010) 1.28
Dynamics of DNA methylation in aging and Alzheimer's disease. DNA Cell Biol (2012) 1.13
Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1. Nucleic Acids Res (2013) 1.04
Epigenetic regulation by RARα maintains ligand-independent transcriptional activity. Nucleic Acids Res (2011) 1.03
The role of redox signaling in epigenetics and cardiovascular disease. Antioxid Redox Signal (2013) 1.03
Phenobarbital mediates an epigenetic switch at the constitutive androstane receptor (CAR) target gene Cyp2b10 in the liver of B6C3F1 mice. PLoS One (2011) 1.00
5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes. Genome Biol (2013) 0.94
Epigenomics and the concept of degeneracy in biological systems. Brief Funct Genomics (2013) 0.92
Bacterial infection remodels the DNA methylation landscape of human dendritic cells. Genome Res (2015) 0.88
Stable transmission of reversible modifications: maintenance of epigenetic information through the cell cycle. Cell Mol Life Sci (2010) 0.86
DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells. Epigenetics Chromatin (2014) 0.85
IL-4 orchestrates STAT6-mediated DNA demethylation leading to dendritic cell differentiation. Genome Biol (2016) 0.83
PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation. Epigenetics (2012) 0.82
ALS and FTD: an epigenetic perspective. Acta Neuropathol (2016) 0.81
The degree of global DNA hypomethylation in peripheral blood correlates with that in matched tumor tissues in several neoplasia. PLoS One (2014) 0.81
Chromatin modifications and genomic contexts linked to dynamic DNA methylation patterns across human cell types. Sci Rep (2015) 0.79
Epigenetic dynamics of monocyte-to-macrophage differentiation. Epigenetics Chromatin (2016) 0.76
1,25-Dihydroxyvitamin D3 promotes a sustained LPS-induced NF-κB-dependent expression of CD55 in human monocytic THP-1 cells. PLoS One (2012) 0.76
Why is epigenetics important in understanding the pathogenesis of inflammatory musculoskeletal diseases? Arthritis Res Ther (2013) 0.76
Activation-induced cytidine deaminase selectively catalyzed active DNA demethylation in pluripotency gene and improved cell reprogramming in bovine SCNT embryo. Cytotechnology (2016) 0.75
Alu repeats as transcriptional regulatory platforms in macrophage responses to M. tuberculosis infection. Nucleic Acids Res (2016) 0.75
DNA methylation: an epigenetic mark of cellular memory. Exp Mol Med (2017) 0.75
Cell-Wide DNA De-Methylation and Re-Methylation of Purkinje Neurons in the Developing Cerebellum. PLoS One (2016) 0.75
Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension. Oncotarget (2017) 0.75
TET2- and TDG-mediated changes are required for the acquisition of distinct histone modifications in divergent terminal differentiation of myeloid cells. Nucleic Acids Res (2017) 0.75
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
DNA methylation patterns and epigenetic memory. Genes Dev (2002) 33.83
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet (2007) 32.41
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
Genomic imprinting: parental influence on the genome. Nat Rev Genet (2001) 11.50
Epigenetics in human disease and prospects for epigenetic therapy. Nature (2004) 11.46
Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell (2003) 10.42
DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell (2008) 8.62
The colorful history of active DNA demethylation. Cell (2008) 8.50
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A (2005) 8.10
Cyclical DNA methylation of a transcriptionally active promoter. Nature (2008) 7.62
Epigenetic reprogramming in mammals. Hum Mol Genet (2005) 6.73
Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature (2010) 6.20
DEMETER DNA glycosylase establishes MEDEA polycomb gene self-imprinting by allele-specific demethylation. Cell (2006) 6.11
Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature (2007) 5.54
Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science (2009) 5.24
Transient cyclical methylation of promoter DNA. Nature (2008) 5.19
Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature (2008) 4.69
DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.30
DNA demethylation by DNA repair. Trends Genet (2009) 3.49
The mononuclear phagocyte system revisited. J Leukoc Biol (2002) 3.01
Retracted DNA demethylation in hormone-induced transcriptional derepression. Nature (2009) 2.90
Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res (2009) 2.87
Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics (2006) 2.68
DEMETER and REPRESSOR OF SILENCING 1 encode 5-methylcytosine DNA glycosylases. Proc Natl Acad Sci U S A (2006) 2.68
Role of the Arabidopsis DNA glycosylase/lyase ROS1 in active DNA demethylation. Proc Natl Acad Sci U S A (2006) 2.46
GADD45A does not promote DNA demethylation. PLoS Genet (2008) 2.36
Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res (2006) 2.22
Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics (2007) 2.01
Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol (1996) 1.99
TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation. Mol Cell (2009) 1.97
Characteristics of human mononuclear phagocytes. Blood (1979) 1.88
PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J Biol Chem (2000) 1.87
Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res (2009) 1.80
Nuclear extracts of chicken embryos promote an active demethylation of DNA by excision repair of 5-methyldeoxycytidine. Proc Natl Acad Sci U S A (1993) 1.69
Conserved DNA methylation in Gadd45a(-/-) mice. Epigenetics (2009) 1.59
Mechanisms of DNA demethylation in chicken embryos. Purification and properties of a 5-methylcytosine-DNA glycosylase. J Biol Chem (1995) 1.57
Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol (1996) 1.46
Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2009) 1.39
Maintenance and regulation of DNA methylation patterns in mammals. Biochem Cell Biol (2005) 1.29
The dynamics of myogenin site-specific demethylation is strongly correlated with its expression and with muscle differentiation. J Biol Chem (2000) 1.15
Regulation of human monocyte DNA synthesis by colony-stimulating factors, cytokines, and cyclic adenosine monophosphate. Blood (1992) 0.99
DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas. Int J Biochem Cell Biol (2007) 0.99
Role of gadd45 in myeloid cells in response to hematopoietic stress. Blood Cells Mol Dis (2007) 0.96
Detection and properties of the human proliferative monocyte subpopulation. J Leukoc Biol (2006) 0.95
X-inactivation and the dynamic maintenance of gene silencing. Mol Genet Metab (2007) 0.87
Direct comparison of the effects of CSF-1 (M-CSF) and GM-CSF on human monocyte DNA synthesis and CSF receptor expression. J Interferon Cytokine Res (1999) 0.86
A promoter-level mammalian expression atlas. Nature (2014) 6.25
Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem (2002) 6.16
The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat Genet (2009) 6.02
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis (2007) 5.15
Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. J Clin Oncol (2013) 4.50
A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol (2010) 4.32
Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature (2013) 3.33
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia. J Clin Oncol (2011) 3.09
Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res (2009) 2.87
Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood (2004) 2.76
Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol (2006) 2.70
Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics (2006) 2.68
Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood (2007) 2.64
Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood (2006) 2.57
Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol Cell (2013) 2.55
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer (2006) 2.40
Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res (2006) 2.22
Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol (2009) 2.22
Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate. Nat Immunol (2012) 2.16
miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol (2009) 2.06
Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics (2007) 2.01
Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial. Clin Cancer Res (2004) 1.92
Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res (2009) 1.80
Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood (2004) 1.76
Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem (2003) 1.73
Of mice and men: species variations of Toll-like receptor expression. Trends Immunol (2002) 1.69
General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res (2010) 1.64
FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J (2010) 1.60
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial. J Clin Oncol (2013) 1.60
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood (2005) 1.58
Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol (2015) 1.58
Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. PLoS Genet (2011) 1.58
Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease. J Invest Dermatol (2011) 1.51
Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood (2004) 1.49
Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood (2003) 1.47
Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. Blood (2006) 1.45
Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Blood (2011) 1.41
Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood (2004) 1.40
Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages. J Immunol (2002) 1.40
Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem (2003) 1.39
Transcription factor PU.1 controls transcription start site positioning and alternative TLR4 promoter usage. J Biol Chem (2007) 1.36
Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood (2012) 1.36
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J Immunol (2003) 1.36
Isolation of CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant (2006) 1.32
Transcriptomic profiling identifies a PU.1 regulatory network in macrophages. Biochem Biophys Res Commun (2009) 1.31
Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology (2010) 1.25
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica (2008) 1.24
Macrophage development from HSCs requires PU.1-coordinated microRNA expression. Blood (2011) 1.22
Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes. J Immunol (2009) 1.22
Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect Immun (2004) 1.21
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer (2003) 1.20
A gene necessary for reproductive suppression in termites. Science (2009) 1.19
Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res (2012) 1.18
Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum. J Immunother (2006) 1.17
Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter. BMC Mol Biol (2006) 1.15
Serum response factor utilizes distinct promoter- and enhancer-based mechanisms to regulate cytoskeletal gene expression in macrophages. Mol Cell Biol (2010) 1.15
Transcription and enhancer profiling in human monocyte subsets. Blood (2014) 1.12
Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naïve Treg. Eur J Immunol (2011) 1.09
Update of the FANTOM web resource: from mammalian transcriptional landscape to its dynamic regulation. Nucleic Acids Res (2010) 1.08
The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations. Blood (2014) 1.08
Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology (2006) 1.07
Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway. Infect Immun (2009) 1.06
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Res (2007) 1.06
The combination of gene perturbation assay and ChIP-chip reveals functional direct target genes for IRF8 in THP-1 cells. Mol Immunol (2010) 1.05
PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages. J Leukoc Biol (2007) 1.04
Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1. Nucleic Acids Res (2013) 1.04
Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells. Infect Immun (2005) 1.00
Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. FASEB J (2012) 0.99
Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol (2006) 0.99
CCAAT enhancer-binding protein beta regulates constitutive gene expression during late stages of monocyte to macrophage differentiation. J Biol Chem (2007) 0.99
An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. J Immunol Methods (2002) 0.99
Interferon-induced programmed death-ligand 1 (PD-L1/B7-H1) expression increases on human acute myeloid leukemia blast cells during treatment. Eur J Haematol (2013) 0.98
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV. Ann Hematol (2013) 0.98
Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett (2008) 0.97
Dominant Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression. J Immunol (2011) 0.97
Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma. Cancer (2004) 0.97
Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR. Nucleic Acids Res (2006) 0.97